← Leaderboards
Samuel Arbes
Univ Of North Carolina Chapel Hill
$42,437,176
Attributed
$46,176,145
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $48.1M · FY2012–22$50M$37.5M$25M$12.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$218,830,529 · 4
By mechanism
UM2$213,855,925 · 2
U01$4,735,860 · 1
R34$238,744 · 1
Top collaborators
- Gary D Slade8 shared
- Inna Evgenievna Tchivileva8 shared
- Roger B Fillingim7 shared
- Karen Kesler6 shared
- William T Barry5 shared
- Gloria David5 shared
- Lynette Keyes-Elstein5 shared
- David N. Ikle3 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Andrea G Nackley$13,815,478
- Inna Evgenievna Tchivileva$1,235,635
- Brian D Strahl$12,633,933
- Mark J Zylka$33,948,391
- Harsha Thirumurthy$12,190,121
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingProtocols DocumentationFundingU-Series Cooperative AgreementsProceduresMonitorData ReportingCollectionAsthmaNational Institute Of Allergy And Infectious DiseaseServicesData CollectionPublicationsAllergic DiseaseStatistical Data InterpretationRandomizedClinical InvestigatorDesignHypersensitivityMemberAutoimmune DiseasesCommunicationCostFunding Opportunities
Grant awards (27)
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$3,000,000
UM2 · FY2022 · AI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$15,793,250
UM2 · FY2021 · AI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$3,499,987
UM2 · FY2021 · AI
Asthma and Allergic Diseases Group$2,779,939
UM2 · FY2021 · AI · contact PI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$292,441
UM2 · FY2021 · AI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$22,638,250
UM2 · FY2020 · AI
Asthma and Allergic Diseases Group$10,601,507
UM2 · FY2020 · AI · contact PI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$10,601,507
UM2 · FY2020 · AI
Asthma and Allergic Diseases Group$4,246,651
UM2 · FY2020 · AI · contact PI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$22,293,250
UM2 · FY2019 · AI
Asthma and Allergic Diseases Group$4,232,633
UM2 · FY2019 · AI · contact PI
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$24,936,248
UM2 · FY2018 · AI
Asthma and Allergic Diseases Group$4,988,921
UM2 · FY2018 · AI · contact PI
Effect of COMT genetic polymorphisms on response to propranolol therapy in Temporomandibular Disorder$558,218
U01 · FY2018 · DE
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$23,794,663
UM2 · FY2017 · AI
Asthma and Allergic Diseases Group$5,560,092
UM2 · FY2017 · AI · contact PI
Effect of COMT genetic polymorphisms on response to propranolol therapy in TMD$465,721
U01 · FY2017 · DE
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$22,761,538
UM2 · FY2016 · AI
Asthma and Allergic Diseases Group$4,049,541
UM2 · FY2016 · AI · contact PI
Effect of COMT genetic polymorphisms on response to propranolol therapy in TMD$1,057,143
U01 · FY2016 · DE
Effect of COMT genetic polymorphisms on response to propranolol therapy in TMD$272,798
U01 · FY2016 · DE
Rho Federal Systems Division, Inc. NIAID DAIT SACCC$23,043,250
UM2 · FY2015 · AI
Asthma and Allergic Diseases Group$4,742,257
UM2 · FY2015 · AI · contact PI
Effect of COMT genetic polymorphisms on response to propranolol therapy in TMD$1,140,009
U01 · FY2015 · DE
Effect of COMT genetic polymorphisms on response to propranolol therapy in TMD$66,223
U01 · FY2015 · DE
Effect of COMT genetic polymorphisms on response to propranolol therapy in TMD$1,175,748
U01 · FY2014 · DE
Effect of COMT genetic polymorphism on response to propranolol therapy in TMD$238,744
R34 · FY2012 · DE